Strategies for long-term gene expression in the skin to treat metabolic disorders

Bibliography

• HENGGE UR, CHAN EF, FOSTER RA, WALKER PS, VOGEL JC: Cytokine gene expression in epidermis with biological effects following injection of naked DNA. Nat. Genet. (1995) 10:161–166.
   PubMed Web of Science ®Google Scholar
• GLASSPOOL-MALONE J, SOMIARI S, DRABICK JJ, MALONE RW Efficient nonviral cutaneous transfection. Mol. Then (2000) 2:140–146.
   PubMed Web of Science ®Google Scholar
• WILLIAMS RS, JOHNSTON SA, RIEDY M, DEVIT MJ, MCELLIGOTT SG, SANFORD JC: Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc. Natl. Acad. Sci. USA (1991) 88:2726–2730.
   PubMed Web of Science ®Google Scholar
• JOHNSTON SA, TANG DC: The use of microparticle injection to introduce genes into animal cells in vitro and in vivo. Genet. Eng. (1993) 15:225–236.
   PubMedGoogle Scholar
• FAN H, LIN Q, MORRISSEY GR, KHAVARI PA: Immunization via hair follicles by topical application of naked DNA to normal skin. Nat. Biotechnol. (1999) 17:870–872.
   PubMed Web of Science ®Google Scholar
• TANG DC, SHI Z, CURIEL DT: Vaccination onto bare skin. Nature (1997) 388:729–730.
   PubMed Web of Science ®Google Scholar
• DOMASHENKO A, GUPTA S, COTSARELIS G: Efficient delivery of transgenes to human hair follicle progenitor cells using topical lipoplex. Nat. Biotechnol. (2000) 18:420–423.
   PubMed Web of Science ®Google Scholar
• ALEXANDER MY, AKHURST RJ: Liposome-medicated gene transfer and expression via the skin. Hum. Mol. Genet. (1995) 4:2279–2285.
   PubMed Web of Science ®Google Scholar
• ROBBINS PB, OLIVER SF, SHEU SM et al.: Peptide delivery to tissues via reversibly linked protein transduction sequences. Biotechniques (2002) 33:190-192, 194.
   Google Scholar
• WHITE PJ, GRAY AC, FOGARTY RD et al.: C-5 propyne-modified oligonucleotides penetrate the epidermis in psoriatic and not normal human skin after topical application. J. Invest. Dermatol. (2002) 118:1003–1007.
   PubMed Web of Science ®Google Scholar
• MEHTA RC, STECKER KK, COOPER SR et al.: Intercellular adhesion molecule-1 suppression in skin by topical delivery of anti-sense oligonucleotides. J. Invest. Dermatol. (2000) 115:805–812.
   PubMed Web of Science ®Google Scholar
• SIPRASHVILI Z, SCHOLL FA, OLIVER SF et al.: Gene transfer via reversible plasmid condensation with cysteine-flanked, internally spaced arginine-rich peptides. Hum. Gene Ther. (2003) 14:1225–1233.
   PubMed Web of Science ®Google Scholar
• ••Promising non-viral gene transfer methodfor in vivo applications.
   Google Scholar
• BRANDEN LJ, SMITH CI: Bioplex technology: novel synthetic gene delivery system based on peptides anchored to nucleic acids. Methods Enzymol. (2002) 346:106–124.
   PubMed Web of Science ®Google Scholar
• YANT SR, MEUSE L, CHIU W et cll.: Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat. Genet. (2000) 25:35–41.
   Google Scholar
• ••Gene transfer system leading to efficientintegration in the genome.
   Google Scholar
• ORTIZ-URDA S, LIN Q, YANT SR et al.: Sustainable correction of junctional epidermolysis bullosa via transposon-mediated nonviral gene transfer. Gene Ther. (2003) 10:1099–1104.
   PubMed Web of Science ®Google Scholar
• ORTIZ-URDA S, THYAGARAJAN B, KEENE DR et al.: Stable nonviral genetic correction of inherited human skin disease. Nat. Med. (2002) 8:1166–1170.
   PubMed Web of Science ®Google Scholar
• ••Efficient site-specific integration in thegenome of human keratinocytes.
   Google Scholar
• GARLICK JA, KATZ AB, FENJVES ES, TAICHMAN LB: Retrovirus-mediated transduction of cultured epidermal keratinocytes. J Invest. Dermatol. (1991) 97:824–829.
   PubMed Web of Science ®Google Scholar
• •Pioneering article about epidermal gene therapy.
   Google Scholar
• DENG H, CHOATE KA, LIN Q, KHAVARI PA: High-efficiency gene transfer and pharmacologic selection of genetically engineered human keratinocytes. Biotechniques (1998) 25:274–280.
   PubMed Web of Science ®Google Scholar
• JENSEN UB, PETERSEN MS, LUND TB, JENSEN TG, BOLUND L: Transgene expression in human epidermal keratinocytes: cell cycle arrest of productively transfected cells. Exp. Dermatol. (2000) 9:298–310.
   PubMed Web of Science ®Google Scholar
• KOLODKA TM, GARLICK JA, TAICHMAN LB: Evidence for keratinocyte stem cells in vitro: long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes. Proc. Natl. Acad. Sci. USA (1998) 95:4356–4361.
   PubMed Web of Science ®Google Scholar
• WHITE SJ, PAGE SM, MARGARITIS P, BROWNLEE GG: Long-term expression of human clotting Factor IX from retrovirally transduced primary human keratinocytes in vivo. Hum. Gene Ther. (1998) 9:1187–1195.
   PubMed Web of Science ®Google Scholar
• DENG H, LIN Q, KHAVARI PA: Sustainable cutaneous gene delivery. Nat. Biatechnol. (1997) 15:1388–1391.
   PubMed Web of Science ®Google Scholar
• LEVY L, BROAD S, ZHU AJ et cll.: Optimised retroviral infection of human epidermal keratinocytes: long- term expression of transduced integrin gene following grafting on to SCID mice. Gene Ther. (1998) 5:913–922.
   Google Scholar
• GHAZIZADEH S, HARRINGTON R, TAICHMAN L: In vivo transduction of mouse epidermis with recombinant retroviral vectors: implications for cutaneous gene therapy. Gene Then (1999) 6:1267–1275.
   PubMed Web of Science ®Google Scholar
• GHAZIZADEH S, KALISH RS, TAICHMAN L: Immune-mediated loss of transgene expression in skin: implications for cutaneous gene therapy. Mal. Ther. (2003) 7:294–295.
   PubMedGoogle Scholar
• BAEK SC, LIN Q, ROBB INS PB, FAN H,KHAVARI PA: Sustainable systemic delivery via a single injection of lentivirus into human skin tissue. Hum. Gene Ther. (2001) 12:1551–1558.
   PubMed Web of Science ®Google Scholar
• HENGGE UR, MIRMOHAMMADSADEGH A: Adeno-associated virus expresses transgenes in hair follicles and epidermis. Mal. Ther. (2000) 2:188–194.
   PubMed Web of Science ®Google Scholar
• DONAHUE BA, MCARTHUR JG, SPRATT SK et al.: Selective uptake and sustained expression of AAV vectors following subcutaneous delivery. J Gene Med. (1999) 1:31–42.
   PubMed Web of Science ®Google Scholar
• JENSEN TG, JENSEN UB, BOLUND L: Production of retroviral vectors in primary human keratinocytes after DNA-mediated gene transfer leads to prolonged gene expression. Acta Derm. Venereal. (2003) 83:83–87.
   PubMed Web of Science ®Google Scholar
• WATT FM: Epidermal stem cells as targets for gene transfer. Hum. Gene Ther. (2000) 11:2261–2266.
   PubMed Web of Science ®Google Scholar
• PFUTZNER W, HENGGE UR, JOARI MA, FOSTER RA, VOGEL JC: Selection of keratinocytes transduced with the multidrug resistance gene in an in vitro skin model presents a strategy for enhancing gene expression in vivo. Hum. Gene Ther. (1999) 10:2811–2821.
   PubMed Web of Science ®Google Scholar
• PFUTZNER W, TERUNUMA A, TOCK CL et al.: Topical colchicine selection of keratinocytes transduced with the multidrug resistance gene (MDR1) can sustain and enhance transgene expression in vivo. Proc. Natl. Acad. Sci. USA (2002) 99:13096–13101.
   PubMed Web of Science ®Google Scholar
• FAKHARZADEH SS, ZHANG Y, SARKAR R, KAZAZIAN HH JR: Correction of the coagulation defect in hemophilia A mice through Factor VIII expression in skin. Blood (2000) 95:2799–2805.
   PubMed Web of Science ®Google Scholar
• •Important article showing that proteins from the skin can correct a disease phenotype.
   Google Scholar
• LARCHER F, DEL RIO M, SERRANO F et al.: A cutaneous gene therapy approach to human leptin deficiencies: correction of the murine ob/ob phenotype using leptin-targeted keratinocyte grafts. FASEB (2001) 15:1529–1538.
   PubMed Web of Science ®Google Scholar
• TAICHMAN LB: Epithelial gene therapy. In: The Keratinocyte Handbook. Leigh IM, Lane B, Watt F (Eds), Cambridge University Press, Cambridge, UK (1994):543–551.
   Google Scholar
• PALMER TD, HOCK RA, OSBORNE WIZ., MILLER AD: Efficient retrovirus-mediated transfer and expression of a human adenosine dearninase gene in diploid skin fibroblasts from an adenosine deaminase-deficient human. Proc. Natl. Acad. Sci. USA (1987) 84:1055–1059.
   Google Scholar
• FENJVES ES, SCHWARTZ PM, BLAESE RM, TAICHMAN LB: Keratinocyte gene therapy for adenosine deaminase deficiency: a model approach for inherited metabolic disorders. Hum. Gene Then (1997) 8:911–917.
   PubMed Web of Science ®Google Scholar
• KAISER-KUPFER MI, DE MONASTERIO F, VALLE D, WALSER M, BRUSILOW S: Visual results of a long-term trial of a low-arginine diet in gyrate atrophy of choroid and retina. Ophthalmology (1981) 88:307–310.
   PubMed Web of Science ®Google Scholar
• KAISER-KUPFER MI, CARUSO RC, VALLE D: Gyrate atrophy of the choroid and retina. Long-term reduction of ornithine slows retinal degeneration. Arch. Ophthalmol. (1991) 109:1539–1548.
   Google Scholar
• JENSEN TG, SULLIVAN DM, MORGAN RA et al.: Retrovirus-mediated gene transfer of ornithine-delta-arninotransferase into keratinocytes from gyrate atrophy patients. Hum. Gene Ther. (1997) 8:2125–2132.
   PubMed Web of Science ®Google Scholar
• SULLIVAN DM, JENSEN TG, TAICHMAN LB, CSAKY KG: Ornithine-delta-arninotransferase expression and ornithine metabolism in cultured epidermal keratinocytes: toward metabolic sink therapy for gyrate atrophy. Gene Then (1997) 4:1036–1044.
   PubMed Web of Science ®Google Scholar
• CHRISTENSEN R, KOLVRAA S, BLAESE RM, JENSEN TG: Development of a skin-based metabolic sink for phenylalanine by overexpression of phenylalanine hydroxylase and GTP cyclohydrolase in primary human keratinocytes. Gene Ther. (2000) 7:1971–1978.
   PubMed Web of Science ®Google Scholar
• CHRISTENSEN R, GUTTLER F, JENSEN TG: Comparison of epidermal keratinocytes and dermal fibroblasts as potential target cells for somatic gene therapy of phenylketonuria. Mal. Genet. Metab. (2002) 76:313–318.
   PubMed Web of Science ®Google Scholar
• CHRISTENSEN R, KOLVRAA S, JENSEN TG: Manipulation of the phenylalanine metabolism in human keratinocytes. Submitted.
   Google Scholar
• SETOGUCHI Y, JAFFE HA, DANEL C, CRYSTAL RG: Ex vivo and in vivo gene transfer to the skin using replication-deficient recombinant adenovirus vectors. J Invest. Dermatol. (1994) 102:415–421.
   PubMed Web of Science ®Google Scholar
• FENJVES ES, GORDON DA, PERSHING LK, WILLIAMS DL, TAICHMAN LB: Systemic distribution of apolipoprotein E secreted by grafts of epidermal keratinocytes: implications for epidermal function and gene therapy. Proc. Natl Acad. Sci. USA (1989) 86:8803–8807.
   PubMed Web of Science ®Google Scholar
• KRUEGER GG, MORGAN JR, JORGENSEN CM et al.: Genetically modified skin to treat disease: potential and limitations./ Invest. Dermatol (1994) 103:76S–84S.
   Google Scholar
• GERRARD AJ, HUDSON DL, BROWNLEE GG, WATT FM: Towards gene therapy for haemophilia B using primary human keratinocytes. Nat. Genet. (1993) 3:180–183.
   PubMed Web of Science ®Google Scholar
• JENSEN UB, JENSEN TG, JENSEN PK et al.: Gene transfer into cultured human epidermis and its transplantation onto immunodeficient mice: an experimental model for somatic gene therapy. J. Invest. Dermatol (1994) 103:391–394.
   PubMed Web of Science ®Google Scholar
• DA COSTA TH, WILLIAMSON DH, WARD A et al: High plasma insulin-like growth factor-II and low lipid content in transgenic mice: measurements of lipid metabolism. J. Endocrinol (1994) 143:433–439.
   PubMed Web of Science ®Google Scholar
• MENG X, SAWAMURA D, INA Set al: Keratinocyte gene therapy: cytokine gene expression in local keratinocytes and in circulation by introducing cytokine genes into skin. Exp. Dermatol (2002) 11:456–461.
   PubMed Web of Science ®Google Scholar
• SUN WH, BURKHOLDER JK, SUN J et al: In vivo cytokine gene transfer by gene gun reduces tumor growth in mice. Proc. Nail Acad. Sci. USA (1995) 92:2889–2893.
   PubMed Web of Science ®Google Scholar
• MENG X, SAWAMURA D, TAMAI K et al.: Keratinocyte gene therapy for systemic diseases. Circulating interleukin 10 released from gene-transferred keratinocytes inhibits contact hypersensitivity at distant areas of the skin. J. Clin. Invest. (1998) 101:1462–1467.
   Google Scholar
• CHENG J, TURKSEN K, YU QC et al: Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice. Genes Dev. (1992) 6:1444–1456.
   Google Scholar
• RIO MD, LARCHER F, MEANA A et ed.: Nonviral transfer of genes to pig primary keratinocytes. Induction of angiogenesis by composite grafts of modified keratinocytes overexpressing VEGF driven by a keratin promoter. Gene Then (1999) 6:1734–1741.
   Google Scholar